WO2013091062A3 - Composés dérivés d'aldimines, compositions pharmaceutiques et utilisation - Google Patents
Composés dérivés d'aldimines, compositions pharmaceutiques et utilisation Download PDFInfo
- Publication number
- WO2013091062A3 WO2013091062A3 PCT/BR2012/000562 BR2012000562W WO2013091062A3 WO 2013091062 A3 WO2013091062 A3 WO 2013091062A3 BR 2012000562 W BR2012000562 W BR 2012000562W WO 2013091062 A3 WO2013091062 A3 WO 2013091062A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aldimine
- drugs
- pharmaceutical compositions
- derived compounds
- medicinal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/04—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C251/10—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
- C07C251/16—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/61—Carboxylic acid nitriles containing cyano groups and nitrogen atoms being part of imino groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/33—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring
- C07C323/35—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring the thio group being a sulfide group
- C07C323/36—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring the thio group being a sulfide group the sulfur atom of the sulfide group being further bound to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/70—Nitro radicals
- C07D307/71—Nitro radicals attached in position 5
- C07D307/72—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2
- C07D307/73—Nitro radicals attached in position 5 with hydrocarbon radicals, substituted by nitrogen-containing radicals, attached in position 2 by amino or imino, or substituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne des composés dérivés d'aldimines, ainsi que des compositions pharmaceutiques contenant ces composés et des excipients pharmaceutiquement acceptables, outre leur utilisation dans le traitement d'infections fongiques de nature médicale et/ou vétérinaire. Il s'est révélé que les aldimines et leurs dérivés présentent une action antifongique égale ou supérieure à celle des médicaments disponibles sur le marché, tels que le fluconazole. Étant donné qu'il s'agit de nouveaux médicaments, la résistance des pathogènes à ces substances est considérablement réduite. La synthèse des aldimines est réalisée au moyen d'un procédé en une seule étape dans lequel la réaction se produit sur une durée de deux minutes avec des rendements compris entre 70 et 98%, ce qui permet une production à large échelle, le procédé étant rapide et de faible coût par comparaison avec celui des autres médicaments disponibles.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI1106432-3 | 2011-09-23 | ||
BRPI1106432 BRPI1106432A2 (pt) | 2011-09-23 | 2011-09-23 | compostos derivados de aldiminas, composiÇÕes farmacÊuticas e uso |
BR102012023898-5A BR102012023898B1 (pt) | 2012-09-21 | 2012-09-21 | Compostos derivados de aldiminas, composições farmacêuticas e uso |
BRBR1020120238985 | 2012-09-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013091062A2 WO2013091062A2 (fr) | 2013-06-27 |
WO2013091062A3 true WO2013091062A3 (fr) | 2013-10-10 |
Family
ID=48669624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR2012/000562 WO2013091062A2 (fr) | 2011-09-23 | 2012-09-24 | Composés dérivés d'aldimines, compositions pharmaceutiques et utilisation |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013091062A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106397233A (zh) * | 2016-08-26 | 2017-02-15 | 南通奥凯生物技术开发有限公司 | 一种医药级乙二胺四乙酸二钠的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4198349A (en) * | 1977-10-06 | 1980-04-15 | William H. Rorer, Inc. | Benzylideneaniline derivatives |
US20090298905A1 (en) * | 2005-04-15 | 2009-12-03 | Fernando Pedro Cossio | Nitrogenatd trans-stilbene analogs, method for the obtention and medical applications thereof |
-
2012
- 2012-09-24 WO PCT/BR2012/000562 patent/WO2013091062A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4198349A (en) * | 1977-10-06 | 1980-04-15 | William H. Rorer, Inc. | Benzylideneaniline derivatives |
US20090298905A1 (en) * | 2005-04-15 | 2009-12-03 | Fernando Pedro Cossio | Nitrogenatd trans-stilbene analogs, method for the obtention and medical applications thereof |
Non-Patent Citations (4)
Title |
---|
CLEITON M. DA SILVA ET AL.: "Schiff bases: A short review of their antimicrobial activities", JOURNAL OF ADVANCED RESEARCH, vol. 2, 2011, pages 1 - 8 * |
K. MOUNIKA ET AL.: "Synthesis, Characterization and Biological Activity of a Schiff Base Derived from 3-Ethoxy Salicylaldehyde and 2-Amino Benzoic acid and its Transition Metal Complexes", J. SCI. RES., vol. 2, no. 3, 2010, pages 513 - 524 * |
MOHAMED N IBRAHIM ET AL.: "Synthesis, Characterization and Study of the Biological activity of Some Aldimines Derivatives", E-JOURNAL OF CHEMISTRY, vol. 3, no. 4, October 2006 (2006-10-01), pages 257 - 261 * |
S.ARULMURUGAN ET AL.: "Biological Activities of Schiff Base and Its Complexes: a Review", RASAYAN J. CHEM., vol. 3, no. 3, 2010, pages 385 - 410 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106397233A (zh) * | 2016-08-26 | 2017-02-15 | 南通奥凯生物技术开发有限公司 | 一种医药级乙二胺四乙酸二钠的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2013091062A2 (fr) | 2013-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2014097151A3 (fr) | Inhibiteurs d'autotaxine | |
MY190561A (en) | New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them | |
WO2013123215A3 (fr) | Médicaments antiviraux pour le traitement d'infections à arénavirus | |
MD20140073A2 (en) | New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them | |
NZ608116A (en) | Triazine-oxadiazoles | |
MD20140072A2 (ro) | Noi compuşi ai pirolului, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin | |
PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
MD4490B1 (ro) | Noi compuşi de indolizină, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin | |
PH12014501967A1 (en) | Benzodioxanes in combination with other actives for inhibiting leukotriene production | |
NZ729037A (en) | Carboxylic acid compound, method for preparation thereof, and use thereof | |
IN2012DN02139A (fr) | ||
WO2009122285A8 (fr) | Analogues d'ocytocine | |
IL192847A (en) | The history of benzamide and the trower, a process for making them and their pharmaceutical preparations | |
WO2013188268A8 (fr) | Composition pharmaceutique ophtalmique topique contenant du pazopanib | |
IL227024A (en) | The 3 heteroarylamino propionic acid derivatives are converted into amino acids, a process for their preparation, their use in the preparation of medicinal preparations and as medical preparations containing them | |
WO2012135615A3 (fr) | Enopeptines, utilisations de celles-ci, et procédés de synthèse de celles-ci | |
PH12014501545A1 (en) | Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof | |
WO2014036502A8 (fr) | Composés de tétracyclines | |
WO2014201016A3 (fr) | Inhibiteurs de la voie moléculaire mitf | |
IN2015DN02999A (fr) | ||
WO2015002755A3 (fr) | Composés pour le traitement du paludisme | |
WO2012155226A8 (fr) | Procédé pour la production de dérivés de pyrostegia venusta, dérivés de pyrostegia venusta, compositions pharmaceutiques et leurs utilisations | |
WO2013188279A8 (fr) | Composition pharmaceutique ophtalmique topique contenant du cediranib | |
WO2012019428A8 (fr) | Dérivés de benzohydrol, procédé de préparation et utilisation pharmaceutique de ceux-ci | |
WO2013091062A3 (fr) | Composés dérivés d'aldimines, compositions pharmaceutiques et utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12859726 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12859726 Country of ref document: EP Kind code of ref document: A2 |